Ann: 2018 AGM Presentation, page-11

Billy - In agreement on all three counts...up to a point

     #1 Agreed - Skint, Pivalde, and others over the years have provided us with great/timely/relevant/highly appreciated information.  At first "decoding it (when possible) was an interesting academic experience.  Now that Parkinson's affects my family, it's even more relevant and the word "appreciation" isn't enough to express my gratitude.

     #2 Agreed, the "PRANA Whigs" as I refer to them, have done well (for themselves), but for our investment?  Not hardly.  I've re-commenced posting since I think they need a wake up call.  

     #3 Held varying numbers of shares for over a decade...AND...I still think PBT2, PBT434, PBT512, and other applications for the attenuators Prana has (and is identifying) are drugs that need to make it to market. 

I still believe the potential for these drugs is enormous. 

Unfortunately, with this "leadership" I'm not prepared to wait another decade.  I...WE need to be dazzled by their performance between now and the next AGM.  If they don't start really moving this thing over the next twelve months we should vote with our feet - I intend to  Those huge options won't be worth much when this stock goes belly up. 

Best of LUCK to you, Billy, and all longs!    ...but PRANA Whigs - you can forget about luck, as Prana's resources fade and (based on the stock price) sentiment suggests indifference, the only thing that's going to save you is performance.